(Q42500610)

1 November 2017

title

CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes (English)

1 reference

1 November 2017

author

Olli-Pekka Kallioniemi

7

1 reference

1 November 2017

9

1 reference

1 November 2017

H Sihto

3

0 references

author name string

M Niemelä

1

1 reference

1 November 2017

O Kauko

2

1 reference

1 November 2017

J-P Mpindi

4

1 reference

1 November 2017

D Nicorici

5

1 reference

1 November 2017

P Pernilä

6

1 reference

1 November 2017

H Joensuu

8

1 reference

1 November 2017

J Westermarck

10

1 reference

1 November 2017

language of work or name

English

0 references

publication date

16 January 2012

1 reference

1 November 2017

1 reference

1 November 2017

volume

31

1 reference

1 November 2017

issue

39

1 reference

1 November 2017

page(s)

4266-4278

1 reference

Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Adenovirus E4orf4 protein downregulates MYC expression through interaction with the PP2A-B55 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Novel c-MYC target genes mediate differential effects on cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Identification of specific PP2A complexes involved in human cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Increase in CIP2A expression is associated with doxorubicin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

CIP2A is associated with human breast cancer aggressivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Genomic targets of the human c-Myc protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

The dependence receptor UNC5H2/B triggers apoptosis via PP2A-mediated dephosphorylation of DAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Creation of human tumour cells with defined genetic elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Repeatability of published microarray gene expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

CIP2A inhibits PP2A in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

CIP2A expression and localization in oral carcinoma and dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Model-based variance-stabilizing transformation for Illumina microarray data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Reflecting on 25 years with MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

PP2A: unveiling a reluctant tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Identification of PP2A complexes and pathways involved in cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Molecular subtypes of breast cancers detected in mammography screening and outside of screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

CIP2A expression is increased in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

From promiscuity to precision: protein phosphatases get a makeover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Multiple pathways regulated by the tumor suppressor PP2A in transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

21 January 2018

MYC and Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Functional genetics and experimental models of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

Species- and cell type-specific requirements for cellular transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.599

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.599

1 reference

Dimensions Publication ID

1 November 2017

1043836135

0 references

1 reference